178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Study finds TNF blockers are not associated with poor pregnancy outcomes

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti
A step closer towards a more effective treatment for osteoarthritis

A step closer towards a more effective treatment for osteoarthritis

by Edna George,Indian Institute of ScienceIn vivo images of mice knee joints obtained from Bruker© Xtreme II on day 7 after intra-articular injection of (a) Cy7 free dye and (b) Cy7-labeled PLGA

A step closer towards a more effective treatment for osteoarthritis

by Edna George,Indian Institute of ScienceIn vivo images of mice knee joints obtained from Bruker© Xtreme II on day 7 after intra-articular injection of (a) Cy7 free dye and (b) Cy7-labeled PLGA
Can science take the STING out of runaway inflammation?

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res
VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages
App tackles problem of 'glue ear' in children

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c
Children with asthma at risk for anxiety

Children with asthma at risk for anxiety

by University of QueenslandCredit: CC0 Public DomainChildren diagnosed with asthma were at significantly increased risk of developing anxiety, a University of Queensland study has found.Researche

Children with asthma at risk for anxiety

by University of QueenslandCredit: CC0 Public DomainChildren diagnosed with asthma were at significantly increased risk of developing anxiety, a University of Queensland study has found.Researche
CRISPR screen identifies new anti-inflammatory drug target

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf
How long does immunity last after COVID vaccination, and do we need booster shots?

How long does immunity last after COVID vaccination, and do we need booster shots?

by Vasso Apostolopoulos, Jack Feehan,The ConversationCredit: Unsplash/CC0 Public DomainAn important factor in achievingherd immunityagainst SARS-CoV-2 (the virus that causes COVID-19

How long does immunity last after COVID vaccination, and do we need booster shots?

by Vasso Apostolopoulos, Jack Feehan,The ConversationCredit: Unsplash/CC0 Public DomainAn important factor in achievingherd immunityagainst SARS-CoV-2 (the virus that causes COVID-19
Could a nasal spray replace an EpiPen? Here's what an allergist says

Could a nasal spray replace an EpiPen? Here's what an allergist says

by Tayler Shaw,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainFor the millions of Americans who have a food allergy, doctors recommend they always carry an epinephrine auto-injector

Could a nasal spray replace an EpiPen? Here's what an allergist says

by Tayler Shaw,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainFor the millions of Americans who have a food allergy, doctors recommend they always carry an epinephrine auto-injector
Updated guidelines released for management of atopic dermatitis

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna

Updated guidelines released for management of atopic dermatitis

by Elana GotkineIn updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in theAnna
Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these